Stay updated on Comparing Bictegravir Triple Therapy in HIV Clinical Trial

Sign up to get notified when there's something new on the Comparing Bictegravir Triple Therapy in HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Bictegravir Triple Therapy in HIV Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and Revision: v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:37:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and the government-funding operating-status notice was removed; core study content and links are unchanged.
    Difference
    0.2%
    Check dated 2026-02-11T14:21:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding-lapse notice and updated the page version from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:22:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary added; new metadata items Last Update Submitted that Met QC Criteria and No FEAR Act Data, plus site revision to v3.4.0; removed older items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T06:19:07.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:08:31.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Consolidated into a single 'Locations' section listing all sites (Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Virginia, Washington, New South Wales, and Victoria) and removed the previous per-location subsections (e.g., 'Arizona Locations', 'California Locations', etc.). The HHS Vulnerability Disclosure item was removed and the revision updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:46:04.000Z thumbnail image

Stay in the know with updates to Comparing Bictegravir Triple Therapy in HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Bictegravir Triple Therapy in HIV Clinical Trial page.